<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-12">
 <label>12</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reding</surname>
    <given-names>MT</given-names>
   </name>
   <name>
    <surname>Ng</surname>
    <given-names>HJ</given-names>
   </name>
   <name>
    <surname>Poulsen</surname>
    <given-names>LH</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIII.</article-title>
  <source>
   <italic>J Thromb Haemost.</italic>
  </source>
  <year>2017</year>;
  <volume>15</volume>(
  <issue>3</issue>):
  <fpage>411</fpage>â€“
  <lpage>9</lpage>. 
  <pub-id pub-id-type="doi">10.1111/jth.13597</pub-id>
  <?supplied-pmid 27992112?>
  <pub-id pub-id-type="pmid">27992112</pub-id>
 </mixed-citation>
 <note>
  <p>
   <ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727123129" xmlns:xlink="http://www.w3.org/1999/xlink">F1000 Recommendation</ext-link>
  </p>
 </note>
</ref>
